4.7 Article

Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 538, 期 1-2, 页码 1-13

出版社

ELSEVIER
DOI: 10.1016/j.ijpharm.2017.12.041

关键词

Supercritical antisolvent; Poorly water-soluble drug; Solubility; Bioavailability; Micronization; Solid dispersion nanoparticles

资金

  1. National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2017R1D1A1B03031213]

向作者/读者索取更多资源

Poor water solubility and poor bioavailability are problems with many pharmaceuticals. Increasing surface area by micronization is an effective strategy to overcome these problems, but conventional techniques often utilize solvents and harsh processing, which restricts their use. Newer, green technologies, such as supercritical fluid (SCF)-assisted particle formation, can produce solvent-free products under relatively mild conditions, offering many advantages over conventional methods. The antisolvent properties of the SCFs used for microparticle and nanoparticle formation have generated great interest in recent years, because the kinetics of the precipitation process and morphologies of the particles can be accurately controlled. The characteristics of the supercritical antisolvent (SAS) technique make it an ideal tool for enhancing the solubility and bioavailability of poorly watersoluble drugs. This review article focuses on SCFs and their properties, as well as the fundamentals of overcoming poorly water-soluble drug properties by micronization, crystal morphology control, and formation of composite solid dispersion nanoparticles with polymers and/or surfactants. This article also presents an overview of the main aspects of the SAS-assisted particle precipitation process, its mechanism, and parameters, as well as our own experiences, recent advances, and trends in development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据